Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ACE inhibitor; hypertension; lipid; risk factor:

Search results

Items: 1 to 20 of 451

1.

Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.

Yan X, Li Y, Dong Y, Wu Y, Li J, Bian R, Hu D.

Lipids Health Dis. 2019 Jan 29;18(1):32. doi: 10.1186/s12944-019-0974-y.

2.

A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes.

Hye Khan MA, Kolb L, Skibba M, Hartmann M, Blöcher R, Proschak E, Imig JD.

Diabetologia. 2018 Oct;61(10):2235-2246. doi: 10.1007/s00125-018-4685-0. Epub 2018 Jul 21.

3.

Atorvastatin, losartan and captopril may upregulate IL-22 in hypertension and coronary artery disease; the role of gene polymorphism.

Akbari H, Asadikaram G, Jafari A, Nazari-Robati M, Ebrahimi G, Ebrahimi N, Masoumi M.

Life Sci. 2018 Aug 15;207:525-531. doi: 10.1016/j.lfs.2018.07.005. Epub 2018 Jul 5.

PMID:
29981321
4.

Changes in albuminuria and renal outcome in patients with type 2 diabetes and hypertension: a real-life observational study.

Viazzi F, Ceriello A, Fioretto P, Giorda C, Guida P, Russo G, Greco E, De Cosmo S, Pontremoli R; AMD-Annals Study Group.

J Hypertens. 2018 Aug;36(8):1719-1728. doi: 10.1097/HJH.0000000000001749.

PMID:
29677050
5.
6.

Reduction in nitric oxide bioavailability shifts serum lipid content towards atherogenic lipoprotein in rats.

Aluko EO, Omobowale TO, Oyagbemi AA, Adejumobi OA, Ajibade TO, Fasanmade AA.

Biomed Pharmacother. 2018 May;101:792-797. doi: 10.1016/j.biopha.2018.03.001. Epub 2018 Mar 22.

PMID:
29525675
7.

The challenge of peripheral arterial disease: How do we improve outcome?

Stock JK.

Atherosclerosis. 2018 Mar;270:196-198. doi: 10.1016/j.atherosclerosis.2017.12.031. Epub 2018 Jan 5. No abstract available.

PMID:
29395100
8.

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.

Brook RD, Kaciroti N, Bakris G, Dahlöf B, Pitt B, Velazquez E, Weber M, Zappe DH, Hau T, Jamerson KA.

J Am Heart Assoc. 2018 Jan 4;7(1). pii: e006940. doi: 10.1161/JAHA.117.006940.

9.

Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Dewland TA, Soliman EZ, Yamal JM, Davis BR, Alonso A, Albert CM, Simpson LM, Haywood LJ, Marcus GM.

Circ Arrhythm Electrophysiol. 2017 Dec;10(12). pii: e005463. doi: 10.1161/CIRCEP.117.005463.

10.

Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.

Lang IM, Badr-Eslam R, Greenlaw N, Young R, Steg PG.

Wien Klin Wochenschr. 2017 Dec;129(23-24):879-892. doi: 10.1007/s00508-017-1248-1. Epub 2017 Sep 14.

11.

[Lipertance® The ASCOT single-pill combination has finally arrived].

Radermecker RP.

Rev Med Liege. 2017 Sep;72(9):416-422. Review. French.

12.

Profiling of cardio-metabolic risk factors and medication utilisation among Type II diabetes patients in Ghana: a prospective cohort study.

Adua E, Roberts P, Sakyi SA, Yeboah FA, Dompreh A, Frimpong K, Anto EO, Wang W.

Clin Transl Med. 2017 Sep 7;6(1):32. doi: 10.1186/s40169-017-0162-5.

13.

Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.

Raebel MA, Dyer W, Nichols GA, Goodrich GK, Schmittdiel JA.

Pharmacotherapy. 2017 Oct;37(10):1204-1214. doi: 10.1002/phar.1994. Epub 2017 Sep 12.

14.

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.

Elajami TK, Alfaddagh A, Lakshminarayan D, Soliman M, Chandnani M, Welty FK.

J Am Heart Assoc. 2017 Jul 14;6(7). pii: e004740. doi: 10.1161/JAHA.116.004740.

15.

Turkish assessment of SURF (SUrvey of Risk Factor Management) study: Control rates of cardiovascular risk factors derived from databases of 15 different levels of health centers in Turkey.

Tokgözoğlu L, Oğuz A, Balcı MK, Temizhan A, Güldal Altunoğlu E, Bektaş O, Aslan G, Iyigün Ö, Kara A, Tanrıverdi Pınar H, Yavuz S, Tekin M, Ercan S, Çelik S, Sezgin Meriçliler Ö, Bozkurt Çakır İ.

Turk Kardiyol Dern Ars. 2017 Jul;45(5):398-407. doi: 10.5543/tkda.2017.39032.

16.

Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.

Grenier J, Goodman SG, Leiter LA, Langer A, Teoh H, Bhatt DL, Cheng AYY, Tan MK, Ransom T, Connelly KA, Yan AT.

Can J Diabetes. 2018 Apr;42(2):130-137. doi: 10.1016/j.jcjd.2017.01.005. Epub 2017 May 25.

PMID:
28552652
17.

A Study to Assess the Therapeutic Effect of Enalapril on Olanzapine Induced Metabolic Syndrome in Wistar Rats.

Arivazhahan A, Bairy LK, Nayak V, Kunder SK.

J Clin Diagn Res. 2017 Feb;11(2):FF01-FF06. doi: 10.7860/JCDR/2017/24049.9380. Epub 2017 Feb 1.

18.

Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.

Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C.

Adv Ther. 2017 Apr;34(4):784-798. doi: 10.1007/s12325-017-0497-8. Epub 2017 Mar 4. Review. Erratum in: Adv Ther. 2017 Jun;34(6):1498-1499.

19.

Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.

Sirenko Y, Radchenko G; PERSPECTIVA Study Group.

High Blood Press Cardiovasc Prev. 2017 Mar;24(1):85-93. doi: 10.1007/s40292-017-0184-5. Epub 2017 Feb 2.

PMID:
28150140
20.

Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Ernst ME, Davis BR, Soliman EZ, Prineas RJ, Okin PM, Ghosh A, Cushman WC, Einhorn PT, Oparil S, Grimm RH Jr; ALLHAT Collaborative Research Group.

J Am Soc Hypertens. 2016 Dec;10(12):930-938.e9. doi: 10.1016/j.jash.2016.10.010. Epub 2016 Nov 9.

Supplemental Content

Loading ...
Support Center